Bioventus (BVS) Income from Continuing Operations (2020 - 2026)
Bioventus' (BVS) quarterly Income from Continuing Operations came in at 3946000.0 in Q1 2026, up 218.78% YoY from 1237829.27 in Q1 2025, and down 77.21% on a QoQ basis from 17318000.0 in Q4 2025.
Bioventus (BVS) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Income from Continuing Operations data on file, last reported at 3946000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 218.78% year-over-year to 3946000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34542000.0 (up 178.52% YoY) and the FY2025 annual result came in at 27274000.0, up 157.97% from the prior year.
- Income from Continuing Operations declined to 3946000.0 in Q1 2026, from 17318000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 17318000.0 in Q4 2025 to a low of 101035000.0 in Q4 2022.
- A 5-year average of 16569176.47 and a median of 6381000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 85808.0% — and 2025, when it surged 2971.97%.
- Tracing BVS's Income from Continuing Operations over 5 years: stood at 21477000.0 in 2022, then soared by 64.35% to 7656000.0 in 2023, then jumped by 92.12% to 603000.0 in 2024, then surged by 2971.97% to 17318000.0 in 2025, then sank by 77.21% to 3946000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3946000.0 (Q1 2026), 17318000.0 (Q4 2025), and 4006000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 36.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 36.21 Mn |
| Mar 28, 2026 | 3.95 Mn |
| Dec 31, 2025 | 17.32 Mn |
| Sep 27, 2025 | 4.01 Mn |
| Jun 28, 2025 | 9.27 Mn |
| Mar 29, 2025 | -3.32 Mn |
| Dec 31, 2024 | -603,000.00 |
| Sep 28, 2024 | -5.85 Mn |
| Jun 29, 2024 | -34.22 Mn |
| Mar 30, 2024 | -6.38 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -8.79 Mn |
| Jul 1, 2023 | -4.73 Mn |
| Apr 1, 2023 | -100.02 Mn |
| Dec 31, 2022 | -21.48 Mn |
| Oct 1, 2022 | -101.04 Mn |
| Jul 2, 2022 | -7.73 Mn |
| Apr 2, 2022 | -14.41 Mn |
| Dec 31, 2021 | -25,000.00 |
| Oct 2, 2021 | -2.27 Mn |